The value of the optical density of BRAF-positive A375 melanoma cells attached to fibronectin was increased 1.87 times, whereas BRAF-negative SK-MEL-2 cells did not show any alteration in adhesion to fibronectin after vemurafenib treatment (Figure 6C). This evidence concerns the gene FN1 and melanoma.